Osteoporosis Associated with Chronic Obstructive Pulmonary Disease

Area of Science:

• Pulmonology
• Endocrinology
• Geriatrics

Background:

• Osteoporosis is a systemic comorbidity increasingly recognized in patients with chronic obstructive pulmonary disease (COPD).
• COPD-associated osteoporosis significantly impacts patients' quality of life, daily activities, respiratory function, and overall prognosis.
• Despite its prevalence, COPD-associated osteoporosis remains under-recognized and undertreated.

Purpose of the Study:

• To highlight the strong association between COPD and osteoporosis.
• To emphasize the clinical risk factors contributing to osteoporosis in COPD patients.
• To advocate for increased awareness and routine screening for osteoporosis in COPD.

Main Methods:

• Review of epidemiological studies and clinical risk factors for osteoporosis in COPD.
• Analysis of factors contributing to decreased bone mineral density and impaired bone quality in COPD patients.
• Discussion of the impact of osteoporosis on COPD patient outcomes.

Main Results:

• Osteoporosis and fractures are highly prevalent in COPD patients, linked to general factors (smoking, age, low weight, inactivity) and disease-specific factors (poor lung function, inflammation, glucocorticoid use, vitamin D deficiency).
• Decreased bone mineral density and impaired bone quality contribute to fractures in COPD.
• Vertebral fractures are particularly common and often overlooked.

Conclusions:

• Increased physician awareness of osteoporosis in COPD is essential, particularly regarding vertebral fractures.
• Routine screening and risk assessment for osteoporosis in COPD patients can lead to earlier diagnosis and intervention.
• Timely prevention and treatment of osteoporosis may improve COPD patients' quality of life, daily activities, lung function, and prognosis.